| John Fitzpatrick, | |
|
4501 Diplomacy Dr, Anchorage, AK 99508-5919 | |
| (907) 729-4955 | |
| Not Available |
| Full Name | John Fitzpatrick |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 21 Years |
| Location | 4501 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881018653 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CHI-LIC-1053 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
Genentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.
Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients - receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines.
As Bill Maher, New York Magazine, the Washington Post and countless cable news and Internet sources have pointed out, the 2010 midterm campaigns and elections seem to have brought to light an American electorate capable of shocking illogic, ignorance and even violence.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
› Verified 9 days ago
| Provider Name | Alaska Native Tribal Health Consortium |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Genentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.
Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients - receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines.
As Bill Maher, New York Magazine, the Washington Post and countless cable news and Internet sources have pointed out, the 2010 midterm campaigns and elections seem to have brought to light an American electorate capable of shocking illogic, ignorance and even violence.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
› Verified 9 days ago
| Provider Name | Southcentral Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
Genentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.
Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients - receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines.
As Bill Maher, New York Magazine, the Washington Post and countless cable news and Internet sources have pointed out, the 2010 midterm campaigns and elections seem to have brought to light an American electorate capable of shocking illogic, ignorance and even violence.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Fitzpatrick, 2021 Garfield St, Butte, MT 59701-6303 Ph: (406) 539-8136 | John Fitzpatrick, 4501 Diplomacy Dr, Anchorage, AK 99508-5919 Ph: (907) 729-4955 |
News Archive
Genentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.
Radiotherapy destroys cancer cells using high-energy ionizing radiation to damage DNA and induce cell death. About two million patients per year in the United States - more than 50 percent of all cancer patients - receive radiotherapy at some stage during their illness, either alone or in combination with chemotherapy, surgery, and targeted medicines.
As Bill Maher, New York Magazine, the Washington Post and countless cable news and Internet sources have pointed out, the 2010 midterm campaigns and elections seem to have brought to light an American electorate capable of shocking illogic, ignorance and even violence.
The Division of Clinical Informatics at Beth Israel Deaconess Medical Center (BIDMC) and the Pan American Health Organization (PAHO) / World Health Organization have signed a framework agreement to collaborate in supporting the advancement of eHealth in Latin America and the Caribbean. BIDMC efforts will be led by Director of Global Health Informatics Yuri Quintana, PhD.
› Verified 9 days ago
Arctic Chiropractic Barrow Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 4000 W Dimond Blvd, Ste #4, Anchorage, AK 99502 Phone: 907-852-3099 Fax: 907-852-3225 | |
Chiro One Wellness Center Of Anchorage South Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 4000 W Dimond Blvd Unit 4, Anchorage, AK 99502 Phone: 907-243-0660 | |
Dr. Jonathan D. Vito, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8840 Old Seward Hwy Ste E, Anchorage, AK 99515 Phone: 907-346-5255 Fax: 907-346-5256 | |
Arctic Rehabilitation And Physical Therapy Anchorage Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 5701 Lake Otis Pkwy, Suite 100, Anchorage, AK 99507 Phone: 907-277-3422 | |
Dr. Kelly Brian Ryan, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 550 E Tudor Rd, Anchorage, AK 99503 Phone: 907-222-2100 Fax: 907-222-2131 | |
Dr. Elliott Shawn Woodmansee, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 750 W Dimond Blvd, Suite 121, Anchorage, AK 99515 Phone: 907-344-0033 Fax: 907-344-6332 | |
Dr. Wesley Moore, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 505 W Northern Lights Blvd, Anchorage, AK 99503 Phone: 907-339-0100 Fax: 907-334-1961 |